Navignostics
Z├╝rich · Founded 2022
About Navignostics
Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.7M
- Funding stage: Seed
- Last round: Seed (Nov 2022)
- Website: https://www.navignostics.com/
- Phone: +41 44 635 66 30
Industries & Categories
Bioinformatics, Biotechnology, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/navignostics-85448 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.